Dr. Grüneberg Discusses Patent Eligibility at Lecture Series in Basel
BASEL, CH (September 29, 2017) – On Tuesday, the Basel Intellectual Property Lecture (BIPL) series welcomed lecturer Dr. Kirsten Grüneberg, who presented on Judicial Exceptions and Patent Eligibility in the U.S.
Subject matter eligibility has become a major topic in U.S. patent law in the past few years, with new developments from the Supreme Court in cases such as Alice v. CLS Bank, Mayo v. Prometheus, and AMP v. Myriad. At the BIPL, Dr. Grüneberg characterized the current landscape as to patent eligibility in the U.S., further offering practical advice for those seeking U.S. patent coverage in technical areas particularly affected by recent developments.
With support from Niizuma Wasner GmbH, F.Hoffmann-La Roche Ltd., the University of Basel, and the European Center of Pharmaceutical Medicine (EPCM), the BIPL provides a forum for discussions on intellectual property. Lecturers include legal professionals and researchers from across the globe. In her lecture this week, Dr. Grüneberg joins a list of prestigious lecturers to appear at this lecture series.
Launched in September 2017, Grüneberg and Myers PLLC is a 100 percent female- and minority-owned international patent firm. With a broad and sophisticated practice, the firm provides a full range of patent support services, including patent prosecution, counseling, post-grant representation, and M&A due diligence to meet the growing and diverse needs of U.S.-based, European, and Asian companies, entrepreneurs, and inventors.